• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

LuCE seeks to fill key roles

Join our team at Lung Cancer Europe (LuCE) and become part of a dedicated group of individuals who are driven […]

ALK Positive Europe joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as Alk Positive Europe joins the LuCE family. […]

Alk+ France cancer poumon joins Lung Cancer Europe

We are very happy that Alk Ros1 France Cancer Poumon has become a member of Lung Cancer Europe (LuCE).Alk+ France […]

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

Some positive news last week when the U.S. Food and Drug Administration (FDA) approved alectinib as an adjuvant treatment for […]

Five new members join the Lung Cancer Europe (LuCE) network

We’re delighted to welcome five new member organisations to our growing Lung Cancer Europe (LuCE) network. These organisations and their […]

New LuCE Board elected at AGM 2024 in Zagreb

We are delighted to announce the new Board of Lung Cancer Europe (LuCE) elected at our AGM in Zagreb last […]